CI vs INVX · P/E 2.4, rev $274.90B vs P/E 8.0, rev $660.8M
Cigna Corp (CI) versus Innovex International, Inc (INVX) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Innovex International, Inc (INVX) is a oil & gas equipment & services company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported INVX revenue for 2024-12-31 was $660.8M. Net income was $140.3M. Revenue was up 55.8% from 2023-12-31 to 2024-12-31. INVX currently screens at market cap $1.10B and trailing P/E 8.0.
CI currently screens at market cap $71.62B and trailing P/E 2.4. INVX currently screens at market cap $1.10B and trailing P/E 8.0.
Not investment advice. Open the CI and INVX stock pages for the full models.
Not investment advice.